Characterization of T cell receptor (TCR) of neurological autoimmune disease-inducing T cells and TCR-based immunotherapy with DNA vaccines
诱导神经系统自身免疫性疾病的 T 细胞的 T 细胞受体 (TCR) 的表征以及基于 TCR 的 DNA 疫苗免疫治疗
基本信息
- 批准号:10357005
- 负责人:
- 金额:$ 20.99万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A).
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In this study, we have modified and applied CDR3 spectratyping analysis which is a sensitive method to detect T cell clonal expansion to identify T cells bearing autoimmune disease-associated T cells (TCR). Based on the results obtained by the analysis, we have made DNA vaccines i.e. expression vectors encoding the Vbeta chain of TCR of encepahlotogenic T cells, and tried to protect animals immunized with neuroantigen plus complete Freund adjuvant from the development of experimental autoimmune encephalomyelitis(EAE). The basic principle of DNA vaccination therapy is as follows. When DNA vaccines are injected in animals, TCR genes are transcribed and translated into TCR oriteubs. Then, these proteins overexpressed in vaccinated animals induce anti-TCR antibodies and/or regulatory T cells, which in tern inhibit the proliferation of encephalitogenic T cells bearing the same TCR.The TCR duagbisus abd DNA vaccination therapy established in animal models will provide useful information to t … More he development of TCR analysis and TCR-based immunotherapy in human diseases in the near future.In EAE induced in Lewiw rats, we found that 1)Vβ8.2 clonal expansion was observed in T cells infiltrating the central nevous system(CNS), 2)this finding was observed not only in the CNS, but also in peripheral blood lymphocyts, enabling the diagnosis of the disease satus using the peripheral blood, and that 3)when the major encephalitogenic T cells bearing Vβ8.2 were depleted with the corresponding antibody, second encephalitogenic T cells bearing Vβ10 were newly activated. These findings suggest that TCR-based immunotherapy should be directed at these T cells simultaneously to obtain sufficient desease suppression.In our recent studies, we identified autoimmune cardititis-inducing T cells that had been not known by CDR3 spectratyping and seceeded in preventing the disease by injection of the corresponding TCR DNA vaccine(J.Immunol., 2000). However, the effects of vaccines on EAE suppression is not sufficient. By improving the vaccine constructs and determining the most effective protocols for vaccine administration, reliable DNA vaccination should be established. Our final goal is to develop TCR-based immunotherapy for human neurological autoimmune diseases. Less
在这项研究中,我们已经修改和应用CDR 3光谱分析,这是一种敏感的方法来检测T细胞克隆扩增,以确定T细胞携带自身免疫性疾病相关的T细胞(TCR)。基于上述分析结果,我们制备了编码致脑炎T细胞TCR V β链的DNA疫苗,并试图保护用神经抗原加完全弗氏佐剂免疫的动物免受实验性自身免疫性脑脊髓炎(EAE)的发展。DNA疫苗治疗的基本原理如下。当将DNA疫苗注射到动物体内时,TCR基因被转录并翻译成TCR位点。这些蛋白在免疫动物体内过表达,诱导产生抗TCR抗体和/或调节性T细胞,从而抑制携带相同TCR的致脑炎性T细胞的增殖。 ...更多信息 在Lewiw大鼠EAE模型中,我们发现:1)在中枢神经系统(CNS)浸润的T细胞中观察到Vβ8.2克隆性扩增; 2)不仅在CNS中观察到,而且在外周血淋巴细胞中也观察到这一发现,这使得利用外周血诊断疾病状态成为可能,3)当携带Vβ8.2的主要致脑炎性T细胞被相应的抗体去除后,携带Vβ10的第二致脑炎性T细胞被新激活。在我们最近的研究中,我们鉴定了自身免疫性心肌炎诱导T细胞,这些细胞通过注射相应的TCR DNA疫苗在预防疾病中的CDR 3谱和分泌是未知的(J.Immunol.,2000)。然而,疫苗对EAE的抑制作用是不够的。通过改进疫苗构建体和确定最有效的疫苗施用方案,应该建立可靠的DNA疫苗接种。我们的最终目标是开发针对人类神经系统自身免疫性疾病的基于TCR的免疫疗法。少
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Y.Matsumoto, Y.Jee & M.Sugisaki: "Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR."J. Immunol.. 164. 2248-2254 (2000)
松本 Y.Jee
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Kogure et al.: "Quantitative analysis of pro- and anti-inflammatory cytokine mRNA in neural graft rejection" J.Neuroimmunol.87. 114-120 (1998)
K.Kogure 等人:“神经移植排斥反应中促炎和抗炎细胞因子 mRNA 的定量分析”J.Neuroimmunol.87。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Matsumoto et al.: "Role of natural killer cells and TCRγδT cells in acute autoimmune encephalomyelitis"Eur.J.Immunol.. 28. 1681-1688 (1998)
Y.Matsumoto 等:“自然杀伤细胞和 TCRγδT 细胞在急性自身免疫性脑脊髓炎中的作用”Eur.J.Immunol.. 28. 1681-1688 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y. Okura et al.: "Analysis of neurotrophic effects of hepatocyte growth factor (HGF) in the adult hypoglossal nerve axotomy model"Eur. J. Neurosci.. 11. 4139 (1999)
Y. Okura 等人:“成人舌下神经轴索切断术模型中肝细胞生长因子 (HGF) 的神经营养作用分析”Eur。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Matsumoto: "Characterization of T cell receptor(TCR)of organ-specific autoimmune disease-inducing T cells and TCR-based immunotherapy with DNA vaccines"J.Neuroimmunol.. 110. 1-12 (2000)
Y.Matsumoto:“器官特异性自身免疫性疾病诱导 T 细胞的 T 细胞受体 (TCR) 的表征以及基于 TCR 的 DNA 疫苗免疫治疗”J.Neuroimmunol.. 110. 1-12 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATSUMOTO Yoh其他文献
MATSUMOTO Yoh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATSUMOTO Yoh', 18)}}的其他基金
Role of cytokines in the lesion repair in the central nervous system
细胞因子在中枢神经系统损伤修复中的作用
- 批准号:
09480216 - 财政年份:1997
- 资助金额:
$ 20.99万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The role of cytokines in autoimmune encephalomyelitis and rejection processes of neural grafts
细胞因子在自身免疫性脑脊髓炎和神经移植排斥过程中的作用
- 批准号:
06680751 - 财政年份:1994
- 资助金额:
$ 20.99万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
PTSD and Autoimmune Disease: Towards Causal Effects, Risk Factors, and Mitigators
创伤后应激障碍 (PTSD) 和自身免疫性疾病:因果效应、危险因素和缓解措施
- 批准号:
10696671 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Build to LEAD – Building partnerships to Link the Exposome to Autoimmune Disease
构建引领 — 建立合作伙伴关系,将暴露组与自身免疫性疾病联系起来
- 批准号:
10871040 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Functional consequences of intergenic autoimmune disease risk variants
基因间自身免疫性疾病风险变异的功能后果
- 批准号:
10655161 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
- 批准号:
10740465 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Development of a novel class of ion channel blockers for the treatment of autoimmune disease
开发一类新型离子通道阻滞剂用于治疗自身免疫性疾病
- 批准号:
10053003 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Collaborative R&D
Enhancing the IMHRD cohort to support study of the exposome in autoimmune disease
加强 IMHRD 队列以支持自身免疫性疾病暴露组研究
- 批准号:
10871488 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Treating pain in autoimmune disease: concurrent use of opioids and biologic medication
治疗自身免疫性疾病的疼痛:同时使用阿片类药物和生物药物
- 批准号:
10607303 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Innate Immune Mediated Changes in Renal Function to Cause Hypertension in Females with Autoimmune Disease
先天免疫介导的肾功能变化导致患有自身免疫性疾病的女性高血压
- 批准号:
10714533 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别:
Novel approaches for the treatment of autoimmune disease
治疗自身免疫性疾病的新方法
- 批准号:
10601899 - 财政年份:2023
- 资助金额:
$ 20.99万 - 项目类别: